Cerebral and Tissue Oximetry Device Market Players:
- Artinis Medical Systems
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Edwards Lifesciences Corp.
- Hamamatsu Photonics KK
- HyperMed Imaging Inc.
- Brain Scientific Inc.
- Masimo Corp.
- Medtronic Plc
- Moor Instruments Ltd.
- Nihon Kohden Corporation
- Sotera Health Co.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cerebral and tissue oximetry device is estimated at USD 202.38 million.
The global cerebral and tissue oximetry device market size was more than USD 190.22 million in 2025 and is anticipated to witness a CAGR of around 7.1%, crossing USD 377.7 million revenue by 2035.
North America cerebral and tissue oximetry device market will secure over 35% share, fueled by increased incidence of heart disease and more FDA approvals, forecast period 2026–2035.
Key players in the market include of Brain Scientific Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nihon Kohden Corporation, Sotera Health Co..
